https://www.selleckchem.com/pr....oducts/sb290157-tfa.
Copyright © 2020 Zhou, Tao, Xia, Guo, Pan, Xiang and Shang.One of the key features of acute myeloid leukemia (AML), a group of very aggressive myeloid malignancies, is their strikingly heterogenous outcomes. Accurate biomarkers are needed to improve prognostic assessment. Glutamate oxaloacetate transaminase 1 (GOT1) is essential for cell proliferation and apoptosis by regulating cell's metabolic dependency on glucose. It is unclear whether the expression level of GOT1 has clinical implications in AML. Therefore, we analyzed the dat
Like
Comment
Share
